185 related articles for article (PubMed ID: 1701654)
1. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
[TBL] [Abstract][Full Text] [Related]
2. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
[TBL] [Abstract][Full Text] [Related]
3. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
Earl PL; Broder CC; Long D; Lee SA; Peterson J; Chakrabarti S; Doms RW; Moss B
J Virol; 1994 May; 68(5):3015-26. PubMed ID: 7512157
[TBL] [Abstract][Full Text] [Related]
4. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.
Broder CC; Earl PL; Long D; Abedon ST; Moss B; Doms RW
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11699-703. PubMed ID: 7972127
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of four novel monoclonal antibodies specific to N51(L6)C46 polypeptide simulating fusogenic core structure of GP41 subunit of HIV-1.
Chen Z; Hong L; Li Z; Fan D; Huang Q; Wang H; Li Z; Xu Z
Hybridoma (Larchmt); 2006 Oct; 25(5):278-82. PubMed ID: 17044783
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein.
Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM
AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal idiotypic and anti-idiotypic antibodies to human immunodeficiency virus type 1 envelope glycoprotein.
Brodeur BR; Faucher S; O'Shaughnessy MV; Hamel J
J Gen Virol; 1991 Jan; 72 ( Pt 1)():51-8. PubMed ID: 1703562
[TBL] [Abstract][Full Text] [Related]
8. Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.
Dickey C; Ziegner U; Agadjanyan MG; Srikantan V; Refaeli Y; Prabhu A; Sato A; Williams WV; Weiner DB; Ugen KE
DNA Cell Biol; 2000 Apr; 19(4):243-52. PubMed ID: 10798448
[TBL] [Abstract][Full Text] [Related]
9. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
[TBL] [Abstract][Full Text] [Related]
10. Murine monoclonal antibodies directed against the transmembrane protein gp41 of human immunodeficiency virus type 1 enhance its infectivity.
Niedrig M; Bröker M; Walter G; Stüber W; Harthus HP; Mehdi S; Gelderblom HR; Pauli G
J Gen Virol; 1992 Apr; 73 ( Pt 4)():951-4. PubMed ID: 1378882
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.
Veronese FD; Rahman R; Kalyanaraman VS; Pal R; Lusso P; Tritch R; Petteway S; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1989 Oct; 5(5):479-86. PubMed ID: 2480151
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
Xu JY; Gorny MK; Palker T; Karwowska S; Zolla-Pazner S
J Virol; 1991 Sep; 65(9):4832-8. PubMed ID: 1714520
[TBL] [Abstract][Full Text] [Related]
13. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.
Earl PL; Broder CC; Doms RW; Moss B
J Virol; 1997 Apr; 71(4):2674-84. PubMed ID: 9060620
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
[TBL] [Abstract][Full Text] [Related]
15. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
Virology; 2006 Aug; 352(1):74-85. PubMed ID: 16725170
[TBL] [Abstract][Full Text] [Related]
16. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.
Gorny MK; Zolla-Pazner S
J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104
[TBL] [Abstract][Full Text] [Related]
17. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
[TBL] [Abstract][Full Text] [Related]
18. Characterization and large production of human monoclonal antibodies against the HIV-1 envelope.
Boyer V; Broly H; Souche S; Madaule P; Rossier J; Zagury D; Desgranges C
Clin Exp Immunol; 1991 Mar; 83(3):452-9. PubMed ID: 1706239
[TBL] [Abstract][Full Text] [Related]
19. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera.
Vella C; Ferguson M; Dunn G; Meloen R; Langedijk H; Evans D; Minor PD
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2603-7. PubMed ID: 7506299
[TBL] [Abstract][Full Text] [Related]
20. Identification of HIV gp41-specific antibodies that mediate killing of infected cells.
Williams KL; Stumpf M; Naiman NE; Ding S; Garrett M; Gobillot T; Vézina D; Dusenbury K; Ramadoss NS; Basom R; Kim PS; Finzi A; Overbaugh J
PLoS Pathog; 2019 Feb; 15(2):e1007572. PubMed ID: 30779811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
